Isaksen

TL3 Regular · Nice, FR

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 26 September 2024 · last posted 4h · groups: pharmacists

126 posts, newest first. Showing up to 150.

Mobile reading experience on long topics Replied, post #3 · Meta › Site feedback · 28 Jul 2026 · 5 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Solubility limits and what a cloudy solution is telling you Replied, post #16 · Pharmacology › Formulation chemistry · 27 Jul 2026 · 3 likes Overfill in a vial is deliberate and accounts for the volume unrecoverable at the end. It is not generosity and it is not a bonus dose.
Subgroup analyses: pre-specified versus discovered Replied, post #3 · Evidence › Trials · 27 Jul 2026 · 10 likes The opening post put the caveat in the right place and I want to underline it. Subgroup analyses are hypothesis-generating unless pre-specified and adequately powered,…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #43 · Practice › Dosing & titration · 23 Jul 2026 · 18 likes The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #60 · Clinical › Bloodwork · 23 Jul 2026 · 18 likes Confirming post #59 from a second method, which matters more than confirming it from a second person. Reference intervals: constructed to contain the central 95% of a…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #51 · Access › Insurance & coverage · 21 Jul 2026 · 12 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
Insurance and replacement policies, compared Replied, post #97 · Sourcing › Logistics · 18 Jul 2026 · 32 likes Worth separating two things that post #96 runs together. Insurance and replacement policies was covered in the wiki last year and the page has a review date on it,…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #123 · Evidence › Journal club · 17 Jul 2026 · 0 likes Post #122 answers the question as asked. The question underneath it is different. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the…
Primary endpoint hierarchies and why order matters — one year on Replied, post #48 · Evidence › Trials · 16 Jul 2026 · 0 likes Post #45 put the caveat in the right place and I want to underline it. Genuine question rather than a rhetorical one: has anyone here actually observed Primary endpoint…
Common supplements people ask about, assessed one at a time Replied, post #42 · Practice › Interactions · 13 Jul 2026 · 3 likes Taking post #41 at face value and following it one step further. A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #73 · Analytics › Impurities & related substances · 13 Jul 2026 · 18 likes That is a fair summary of where the discussion has got to.
Follow-up: How compounding permissions changed when supply normalised Replied, post #14 · Sourcing › Regulatory · 12 Jul 2026 · 2 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.
What I would want from a home test that does not exist yet — what changed since Replied, post #91 · Analytics › Home & field testing · 12 Jul 2026 · 22 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
Prior authorisation: what the criteria usually require — a second dataset Started this topic · Access › Insurance & coverage · 4 Jul 2026 · 0 likes Posting this under the heading it deserves: Prior authorisation: what the criteria usually require — a second dataset Everything below is what sits behind that. Posting…
Journal club: what we got wrong in an earlier session Replied, post #47 · Evidence › Journal club · 2 Jul 2026 · 7 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. One more caveat and then I will stop qualifying: the…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #13 · Evidence › Journal club · 1 Jul 2026 · 12 likes Where I part company with post #11, and it is a narrow parting. Reading order that works for these sessions: registry entry, methods, baseline table, primary result,…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #50 · Analytics › HPLC & UHPLC · 27 Jun 2026 · 27 likes Confirming post #48 from a second method, which matters more than confirming it from a second person. Particle size and column dimensions determine what resolution is…
Tracking a shortage from primary sources rather than rumour Replied, post #64 · Access › Shortages · 22 Jun 2026 · 12 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
Pooling trials with different estimands Replied, post #36 · Evidence › Meta-analyses · 20 Jun 2026 · 17 likes Subgroup meta-analysis multiplies the usual subgroup problems by the number of included trials. Treat it as hypothesis-generating without exception.
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #5 · Compounds › Retatrutide · 18 Jun 2026 · 14 likes Post #3 is right about the mechanism and I think understates the practical bit. The claim about retatrutide discussion upthread is stronger than its source supports. I…
About the Receptor biology category Replied, post #4 · Pharmacology › Receptor biology · 18 Jun 2026 · 20 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #42 · Clinical › Comorbidities · 17 Jun 2026 · 3 likes PCOS and metabolic overlap came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Pooling trials with different estimands Replied, post #29 · Evidence › Meta-analyses · 16 Jun 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #81 · Data & Tools › Datasets · 16 Jun 2026 · 1 like Version the file rather than editing in place. A dataset that changes silently under an analysis makes the analysis unreproducible. Not a strong opinion, just a…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #124 · Practice › Storage & stability · 10 Jun 2026 · 0 likes Post #123 answers the question as asked. The question underneath it is different. Two things can be true about reconstituted at once: the mechanism is plausible and the…
Alcohol: what is documented and what is folklore Replied, post #44 · Practice › Interactions · 6 Jun 2026 · 0 likes I would put moderate confidence on the mainstream reading of alcohol and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #23 · Practice › Reconstitution · 5 Jun 2026 · 19 likes Thank you for taking the time. That was more work than a reply usually is.
Second pass at: Programming during a large energy deficit Started this topic · Nutrition & Training › Resistance training · 23 May 2026 · 33 likes Posting this under the heading it deserves: Second pass at: Programming during a large energy deficit Everything below is what sits behind that. Two things I would like…
Comparing documentation quality across the directory, tabulated Replied, post #3 · Sourcing › Vendor reports · 23 May 2026 · 17 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
Reading a trial's population section before its results Replied, post #40 · Evidence › Trials · 21 May 2026 · 22 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #21 · Evidence › Journal club · 16 May 2026 · 1 like Confirming post #20 from a second method, which matters more than confirming it from a second person. The figures usually contain the finding and the text usually…
A single out-of-range value on an otherwise normal panel Replied, post #46 · Clinical › Bloodwork · 14 May 2026 · 5 likes Nothing in this subcategory is medical advice, and a panel with an unexpected result is precisely the situation where that matters. The evidence for this is thinner…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #18 · Evidence › Journal club · 12 May 2026 · 0 likes Where the STEP 1 discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #91 · Clinical › Bloodwork · 3 May 2026 · 13 likes The arithmetic in post #88 is right; the assumption feeding it is the part to check. A note on scope: what I am saying about reference intervals applies to the case in…
The "under review" status pill and when a moderator applies it Replied, post #111 · Evidence › Preprints · 3 May 2026 · 7 likes This follows post #108 rather than contradicting it. The honest position on most preprints in this field is that they are interesting and provisional, and that saying…
Transporting a vial for a weekend away — a second dataset Replied, post #41 · Practice › Storage & stability · 30 Apr 2026 · 0 likes Adding a null result on Transporting a vial. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #56 · Practice › Reconstitution · 21 Apr 2026 · 1 like Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
[2026 update] Composite endpoints and the component doing the work Replied, post #77 · Evidence › Trials · 19 Apr 2026 · 2 likes The version of Composite endpoints that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #33 · Outcomes › Progress reports · 18 Apr 2026 · 0 likes The arithmetic in post #30 is right; the assumption feeding it is the part to check. Nothing here is medical advice and a progress report is a description of what…
Sample handling between despatch and injection Replied, post #47 · Analytics › Method validation · 17 Apr 2026 · 0 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. The evidence for this is…
List price versus negotiated price versus what you pay Replied, post #104 · Access › Pricing · 16 Apr 2026 · 1 like Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #80 · Practice › Interactions · 3 Apr 2026 · 0 likes Confirming post #79 from a second method, which matters more than confirming it from a second person. Timing separation is the standard mitigation where absorption rate…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #11 · Evidence › Journal club · 19 Mar 2026 · 20 likes Post #8 is the version of this I will quote in future. One addition. Adding the boring version of SURMOUNT-4 and continuation versus withdrawal, because the interesting…
Foaming during reconstitution and whether it matters — the long version Replied, post #65 · Practice › Reconstitution · 16 Mar 2026 · 7 likes Where I part company with post #63, and it is a narrow parting. One more thing on Foaming during reconstitution that took me far too long to see: the two figures people…
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #5 · Compounds › Other compounds · 7 Mar 2026 · 20 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
The lowest dose that does anything: is that a real question? Replied, post #67 · Practice › Dosing & titration · 5 Mar 2026 · 7 likes Narrowing post #64, because the general version has more than one answer. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #13 · Research Methods › N-of-1 designs · 24 Feb 2026 · 13 likes Measure the same thing the same way at the same time of day. Most of the noise in personal data is measurement protocol rather than biology. Reading it again, the…
Run-in periods and the population they select Replied, post #70 · Evidence › Trials · 21 Feb 2026 · 18 likes A definition problem is doing most of the work in this run-in periods discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #41 · Sourcing › Logistics · 19 Feb 2026 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #104 · Clinical › Special populations · 18 Feb 2026 · 0 likes Post #100 describes the usual case. This is about the unusual one. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires…
Oral semaglutide bioavailability and its variability between people Replied, post #35 · Compounds › Oral incretins · 15 Feb 2026 · 11 likes Answering the question post #31 raises rather than the one it answers. Dose equivalence between oral and injectable formulations is not a simple conversion and no…
Follow-up: Reconciling a label claim with a content assay Replied, post #6 · Analytics › COA interpretation · 14 Feb 2026 · 12 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Reading this Reconciling a label claim thread as someone who came in with a fixed…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #34 · Analytics › Impurities & related substances · 14 Feb 2026 · 29 likes An impurity profile that changes between lots is more informative than the total. A stable profile suggests a controlled process; a shifting one suggests something is…
Reading SURMOUNT-1 without the press release — one year on Replied, post #47 · Compounds › Tirzepatide · 14 Feb 2026 · 16 likes Noted, and I have changed what I was going to do on the strength of it.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #34 · Outcomes › Progress reports · 11 Feb 2026 · 27 likes Post #33 answers the question as asked. The question underneath it is different. A note on scope: what I am saying about Seven-day rolling applies to the case in the…
Pharmacy supply in the UK and the questions you will be asked Replied, post #30 · Regional › UK & Ireland · 4 Feb 2026 · 7 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #2 · Sourcing › Red flags · 1 Feb 2026 · 1 like That is a cleaner way of putting what I was circling around.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #93 · Practice › Interactions · 19 Jan 2026 · 6 likes An update on my earlier Warfarin and altered intake post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #97 · Compounds › Semaglutide · 19 Jan 2026 · 4 likes Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #8 · Clinical › Special populations · 6 Jan 2026 · 0 likes Everything in post #6 holds. The case it does not cover is the one I have. Body weight at the extremes of the studied range affects exposure and the trials rarely…
Second pass at: Metformin co-administration and additive GI effects Replied, post #21 · Practice › Interactions · 20 Dec 2025 · 1 like Practical note on Metformin co-administration: write down what you expect before you look. The number of times I have found what I went looking for is higher than…
Waist circumference technique and its repeatability Replied, post #27 · Outcomes › Progress reports · 15 Dec 2025 · 27 likes I read post #23 twice before replying, because I had assumed the opposite. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #119 · Practice › Reconstitution · 13 Dec 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Tracking a preprint to publication: a worked example Replied, post #66 · Evidence › Preprints · 6 Dec 2025 · 4 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Why a compound being unapproved is not the same as being illegal to possess Replied, post #35 · Sourcing › Regulatory · 25 Nov 2025 · 0 likes The bit of compound being unapproved that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
Research-use-only labelling: what it means and what it does not Replied, post #58 · Sourcing › Regulatory · 12 Nov 2025 · 5 likes This follows post #57 rather than contradicting it. Distinguishing three things in the research-use-only labelling discussion that keep getting used interchangeably:…
Documentation that materially improves an appeal's chances Replied, post #59 · Access › Insurance & coverage · 11 Nov 2025 · 8 likes Post #57 is right about the mechanism and I think understates the practical bit. Denial letters: the stated reason tells you exactly what to submit next. A denial is…
What a purity-only report leaves out Replied, post #72 · Sourcing › Independent verification · 3 Nov 2025 · 13 likes The documentation on purity-only is better than this thread and I say that as someone who has posted in the thread.
EU-wide position versus national implementation — what changed since Replied, post #5 · Regional › European Union · 19 Oct 2025 · 2 likes The opening post and I disagree about the size of the effect, not about the direction. Date every claim. Positions in this subcategory have moved repeatedly and the…
History of disordered eating and why it changes the conversation Replied, post #17 · Clinical › Special populations · 13 Oct 2025 · 16 likes Practical answer on history of disordered eating, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
A parcel that arrived warm: a decision process, not a verdict Replied, post #74 · Practice › Storage & stability · 8 Oct 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
The headache that turns out to be dehydration Replied, post #4 · Nutrition & Training › Hydration & electrolytes · 22 Sep 2025 · 0 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
Managing an unplanned gap in supply — what changed since Replied, post #66 · Access › Shortages · 19 Sep 2025 · 1 like Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
Thyroid function tests during substantial weight change Replied, post #58 · Clinical › Bloodwork · 11 Sep 2025 · 14 likes Following this. I have the same question and no better information than the first post.
When a preprint is the best available evidence and we say so Replied, post #161 · Evidence › Preprints · 9 Sep 2025 · 15 likes Reading back through, this was answered upthread and I missed it. My fault.
Documentation that appears only after payment Replied, post #12 · Sourcing › Red flags · 26 Aug 2025 · 5 likes Post #8 put the caveat in the right place and I want to underline it. Nothing here should be read as an accusation against a named company, and the guidelines exist so…
Follow-up: Why appetite effects are mostly central Replied, post #21 · Pharmacology › Receptor biology · 19 Aug 2025 · 0 likes Two claims get bundled together under appetite effects and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
A request that was declined, and the reasoning — a second dataset Replied, post #38 · Documentation › Wiki requests · 9 Aug 2025 · 5 likes Everything in post #34 holds. The case it does not cover is the one I have. If a request is declined, the reasoning is written down, and it is worth reading because it…
Hypertension improvement and when medication needs revisiting Replied, post #2 · Clinical › Comorbidities · 8 Aug 2025 · 10 likes This follows the opening post rather than contradicting it. I would be cautious about generalising from the hypertension improvement example above. It is a good…
Are there stupid questions here? A staff answer, at length Replied, post #37 · Start Here › Welcome · 3 Aug 2025 · 1 like The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #37 · Practice › Dosing & titration · 2 Aug 2025 · 26 likes That is a fair summary of where the discussion has got to.
A ten-fold dose error caught before injection — one year on Started this topic · Devices › Syringes & needles · 31 Jul 2025 · 4 likes On the subject in the title: A ten-fold dose error caught before injection — one year on Working notes rather than a conclusion. Two things I would like separated…
Canadian access and provincial variation — one year on Replied, post #48 · Regional › North America · 29 Jul 2025 · 15 likes Adding a data point of agreement rather than a data point.
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #85 · Evidence › Trials · 23 Jul 2025 · 21 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #20 · Compounds › Oral incretins · 22 Jul 2025 · 3 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2025 · 1 like Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were developed to be used together rather than instead of each other.…
A field-by-field walk through a certificate of analysis Replied, post #19 · Analytics › COA interpretation · 14 Jul 2025 · 9 likes Post #17 put the caveat in the right place and I want to underline it. The failure mode on field-by-field walk through a certificate is boring rather than dramatic. It…
Ipamorelin selectivity claims and where they came from Replied, post #53 · Compounds › Secretagogues & GH axis · 3 Jul 2025 · 0 likes On analysis: these are short peptides and generally straightforward chromatographically, which means a poor purity result is more likely to reflect the synthesis than…
Coming back to: What published stability data actually covers, and what it does not Replied, post #61 · Practice › Storage & stability · 11 Jun 2025 · 18 likes Door storage in a refrigerator is the warmest and most variable position in the appliance. A shelf at the back is a materially different environment. That is where I…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #103 · Compounds › Tirzepatide · 6 Jun 2025 · 27 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #2 · Access › Insurance & coverage · 26 May 2025 · 26 likes A request rather than an answer: could whoever has the primary source for Reading a denial letter post it? I have seen the claim three times this month and each version…
DXA precision and the least significant change for lean mass — the long version Replied, post #75 · Outcomes › Body composition · 21 May 2025 · 14 likes I had written a reply contradicting post #73 and deleted it. Here is what survived. DXA (dual-energy X-ray absorptiometry): the standard for body composition in…
DXA precision and the least significant change for lean mass — the long version Replied, post #31 · Outcomes › Body composition · 12 May 2025 · 30 likes Post #29 describes the usual case. This is about the unusual one. Air displacement plethysmography and hydrostatic weighing have their own precision limits and their…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #75 · Sourcing › Independent verification · 10 May 2025 · 31 likes Adding a reference point for Janoshik. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
Follow-up: Requesting a page: what makes a good request Replied, post #28 · Documentation › Wiki requests · 30 Apr 2025 · 14 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
Validating a calculator against hand arithmetic — what changed since Replied, post #41 · Data & Tools › Calculators · 30 Apr 2025 · 8 likes Confirming post #40 from a second method, which matters more than confirming it from a second person. Validating a calculator against hand came up in a thread eighteen…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 18 Apr 2025 · 1 like Combination products complicate the certificate question considerably. Two active components mean two purity determinations and a ratio, and a single figure for a…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #29 · Evidence › Journal club · 18 Apr 2025 · 0 likes I think the STEP 1 question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Carryover and the ghost peak from last week's standard Replied, post #46 · Analytics › HPLC & UHPLC · 7 Apr 2025 · 0 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
Scheduled maintenance and what will be unavailable Replied, post #87 · Meta › Announcements · 27 Mar 2025 · 0 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. Filing this under things that are true until someone…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #18 · Sourcing › Vendor reports · 15 Mar 2025 · 0 likes Post #14 put the caveat in the right place and I want to underline it. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass…
Follow-up: Open-label extensions: what survives and what does not Replied, post #8 · marked as the solution · Evidence › Trials · 9 Mar 2025 · 18 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Fibre intake when total intake falls, and the constipation link Replied, post #34 · Nutrition & Training › Protein & intake · 28 Feb 2025 · 0 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #2 · Evidence › Journal club · 18 Feb 2025 · 0 likes Where I part company with the opening post, and it is a narrow parting. I have been on both sides of the SURMOUNT-OSA argument in this category within eighteen months,…
How compounding permissions changed when supply normalised Replied, post #18 · Sourcing › Regulatory · 11 Feb 2025 · 3 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. That is the version I would…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #92 · Evidence › Meta-analyses · 11 Feb 2025 · 13 likes Two sentences on Random versus fixed effects and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow.…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #137 · Clinical › Prescriber conversations · 2 Jan 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #68 · Evidence › Journal club · 22 Dec 2024 · 23 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. I am confident…
A promotion I argued against, and why I lost Replied, post #27 · Documentation › Doc review · 11 Dec 2024 · 11 likes Posting my promotion numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular…
Why "any advice?" is the least effective ending for a post Replied, post #89 · Start Here › How to Ask · 30 Nov 2024 · 2 likes Second this, and I would have said it less carefully.
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #22 · Nutrition & Training › Protein & intake · 26 Nov 2024 · 0 likes A target that is not being met is worth adjusting downward to something achievable rather than being missed indefinitely.
How to ask for a dose change without antagonising anyone — what changed since Replied, post #58 · Clinical › Prescriber conversations · 13 Nov 2024 · 3 likes Post #57 answers the question as asked. The question underneath it is different. Bringing a record of symptoms with dates and severities makes an assessment materially…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #112 · Analytics › COA interpretation · 10 Nov 2024 · 25 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Revisiting: Moderation log format change Replied, post #16 · Meta › Announcements · 4 Nov 2024 · 15 likes I would put moderate confidence on the mainstream reading of Moderation log format change and no more. That is not scepticism for its own sake; it is where the sourcing…
Follow-up: Dead volume across syringe and needle combinations Replied, post #52 · Devices › Syringes & needles · 20 Oct 2024 · 0 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #9 · Clinical › Special populations · 15 Oct 2024 · 4 likes This settles it for me, at least until somebody posts a reason it should not.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #3 · Evidence › Journal club · 4 Oct 2024 · 1 like That is consistent with mine, for whatever one more account is worth.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #33 · Sourcing › Independent verification · 3 Sep 2024 · 11 likes The lot identifier has to match across vial, certificate and invoice for any of this to mean anything. It is the floor and it is worth checking every time. This is the…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #3 · Practice › Administration · 31 Aug 2024 · 32 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
How to ask for a dose change without antagonising anyone Replied, post #20 · Clinical › Prescriber conversations · 30 Aug 2024 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #29 · Evidence › Journal club · 29 Aug 2024 · 8 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I would be…
Signs of dehydration worth acting on Replied, post #5 · marked as the solution · Safety › Adverse events · 14 Aug 2024 · 31 likes Signs of dehydration worth acting has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Promotion criteria, and the one that stops most nominations Replied, post #36 · Documentation › Doc review · 11 Aug 2024 · 10 likes This is the first time the answer has come with its own limits attached. Appreciated.
Oral contraceptives and delayed emptying: what the data shows Replied, post #37 · Practice › Interactions · 13 Jul 2024 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
The mass-error checker and its intended scope Replied, post #37 · Data & Tools › Calculators · 8 Jun 2024 · 16 likes This follows post #35 rather than contradicting it. Precision and significant figures: the calculators do not round to match your input precision. If you input values…
Assessing a warm arrival: the decision process — one year on Replied, post #112 · Sourcing › Logistics · 1 Jun 2024 · 8 likes Adding a data point of agreement rather than a data point.